{"id":954135,"date":"2026-04-23T08:17:52","date_gmt":"2026-04-23T12:17:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/"},"modified":"2026-04-23T08:17:52","modified_gmt":"2026-04-23T12:17:52","slug":"belite-bio-to-participate-in-four-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/","title":{"rendered":"Belite Bio to Participate in Four Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, April  23, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PSKD7F11HmyWQKQH5HNwGqmQUAOBhGPDSXY-tBwNCoob15Mhfonbea_uzNvk90aFLA9UY6irs8EuXr2YjuTDLNhdUnMSaL7pRbqRIRDy_7S4vZ0lTt1Bv387PH20h1PLSx6rZ6ZySjHOEQl-YzOJw7mFhZHNOZ1vVsIbs69qinRV30VHYyc5fw2kvQ7wYTlxXuogUmrkJxhUz-SF1iDl42WFHAOcZXCoaoVNA3-Od_U=\" rel=\"nofollow\" target=\"_blank\">Belite Bio<\/a>, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:\u00a0\u00a0<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;text-align:justify\">Deutsche Bank American Depositary Receipt Virtual Investor Conference (Virtual)\n<ul type=\"circle\">\n<li style=\"margin-bottom:8pt;text-align:justify\">April 28, 2026, at 9:00 am ET, corporate presentation<\/li>\n<\/ul>\n<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">BofA Securities 2026 Health Care Conference (Las Vegas, NV)\n<ul type=\"circle\">\n<li style=\"margin-bottom:8pt;text-align:justify\">May 13, 2026, at 3:40 pm PT, fireside chat<\/li>\n<\/ul>\n<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">H.C. Wainwright 4<sup>th<\/sup> Annual BioConnect Nasdaq Investor Conference (New York, NY)\n<ul type=\"circle\">\n<li style=\"margin-bottom:8pt;text-align:justify\">May 19, 2026, at 5:00 pm ET, fireside chat<\/li>\n<\/ul>\n<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">Stifel 2026 Virtual Ophthalmology Forum (Virtual)\n<ul type=\"circle\">\n<li style=\"margin-bottom:8pt;text-align:justify\">May 26, 2026, at 12:30 pm ET, fireside chat<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n        <strong>Webcast Link Instructions<\/strong><br \/>\n        <br \/>Webcasts of the presentations can be accessed under &#8220;Events&#8221; in the investor relations section of the Belite Bio website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H2xgKSicgazGUomrfohl1po1blS4biA7BqU4RoMpKQuTCGk7gIHtHC1tUaDaTKfNvhJaxiuuLR0tJ50c1-Ytv0Kt4KAMSp03mTY1EQHV8d2rb3YsZn-gAy3BOGB-3GNggBfZldbT-9APT1evhiJp4B-tRJKD56M8rvwW_jrIlvR6x1ncrA8p8YyMKjDVBc7_pVronMcSziva8UDasf9Vug==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.belitebio.com\/presentations-events\/events<\/a>. The replays will be archived for 90 days following the presentation date.<\/p>\n<p>\n        <strong>About Belite Bio<\/strong><br \/>\n        <br \/>Belite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical need, such as Stargardt disease type 1 (STGD1) and geographic atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite Bio\u2019s lead candidate, tinlarebant, is an oral therapy intended to reduce the accumulation of bisretinoid toxins in the eye. The Company has completed a Phase 3 trial (DRAGON) in adolescent STGD1 subjects, and the drug is currently being evaluated in a Phase 2\/3 trial (DRAGON II) in adolescent STGD1 subjects and a Phase 3 trial (PHOENIX) in subjects with GA. For more information, follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GJ0n3_3uYweTYK4n1ewqGNcJiijJO2H03W5wAX5YpTlDPneszH8j3SxZBD8Zto2EJMJug9uI4WhSGIS_IGkoPyMYqwxf7ugsUdq6ZcQkKqfGu6vByUQJJtuJR4u2salAL5dN02fwq187q5_56Q3_0quTRcrbQId8tqjZIq6W3OIQtTQYe0TFsMAC2MemLS1ifQxgopLupiVJVnrx7SCL6yQFOLg-yoeuQ2DoikVtn-6J5yK4Hb64HWJrAxy_nCu30i3rSyDNe3JMpmQcqf5eWr6qT044u_Us27HQ4IiaKTf0oGxQ_2MQnj0DNrY6fHze1wdT7Twqm52bilRq9wL4XDHrOhpgEU6bvzFTKQJ8IFdmgAOz8v7sXJiiOlmdXZO9\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AqIYcgL4OEalzBqHp3nCA6KY8GNvTgsc3XnbGiWECX5BC4AG8qGNnPOrA4CAfI_WFxHuBs3OX4oiNmnWzSXIoh6BOVXaxtSvDxnFc40PeIURajSlWQLYW09qbC3Z-PFYcPtNmVVqOdSe91_PsAmhi3dTplvyrpJFBQnYN0N2rJkpxDTsEQ86NTZy-z1FXEQh2GoLR8se1P_jADhu4tjAKj_SDgOIp15r6MxeYjJKqdZvoADoKl5GocfCFmpMYx8j55xI2fI-73B-uc8ZxgSW3TYbx3AXPHaGah_dSWzs8CELSb3wXHXRiIR-Z1RcK0q9Pb1qAVjqr3tVLC1zjwhs-8Is4oeZ5W1_hHW0PsegkXkfgL9Kt8ZOlnU8KcXSCMfcWW6M1lGqH1X7r1MjMnZ7Vnkt6XrhGtWU_kMHDUv5WDiM2PPVullLYkng3Qf0-6XC\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xNalBZ1jcpp323KdIBV3rkYyYhUdMo9Pyn0A_oeb0HcqmPYcpVoSjGH7LNxcaCMmUjBMcumtx3jShYzFi8u3zKYGgAOcTd3Zbp7RwSgDcWJtr_5IhBofFWAc1jJsNjqGtmpny380x4jKNQEVEJc6ikyjzKax07RVk5xj1NjVAz6g1IG2HNyoZHtjF3__bVo9sVFnC1Lt1n1iR8gQe2icejORXTH7ajqH2y_VCbb-w5bNHBnWBRLLUrd2GX0BCwfTQH7NbXJxTBNlk4ukLjPq2X_CDQIsrQ7w_D0aV-l4SAD3aFjX7sEBSfd0_DW16dB2k3m-EtbONJdsxnoCiSHx3QjPYRDQe6speax5EfT4JoCVBKOIUIG0UUiA5j07ZRuMCe4v-bFEWxFgZETxPmfYShhwnk9D5QrcxoZOmBDCATnN9RV_HY0nO07J1CtsKRVb\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9dV3F9aSmEXyT3kmeKOQwx8hhKKoVze1_tKFfdvfKkwCkx7qD2giPn8hN-yRnx_8b79VF4Gd44DaJDyGuCQO1gZzsS-PoCMHIANiMj2Kp12ZRXd-NE0Hd5g8Ac4pizKeyTPTSoUb8VPc1Q57RiNizVGhCjrvF_Xga67pSfNvlBRSnsKqHXnmicJq7PMPtUk7DfzHjVN6t-X2cC3NnnWa6AnHhq3Yuu7q3rzbP6JmbjicnoR6Plgev7GmdkiY686v7EAjzvqDK4KSD7SMW0Vcd0P4lm52eOjUTCL6Rd0wjVxE2paBM202CUPddZHcf5qpomCIDoWIOzNqM64qgMhbtFLFbMaXmOs0ODd2yWQhNLc-dBolbKmma6Z5rKRDtECLQJSnfjVokeT6PkGwwoG79Zh0-u-yG_CO6YwPqeOOlICa4hXoofY1lfe8aBspyDIY\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, or visit us at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xqCHtdZvOGBhRh4tT5l3QDQZS3OrWv3p0y_WNvDGArJxpqZJyxTAdIvFnCZFkCTiUJ322P2d3Z3eIRJi7w7ht2tCKXVvePOQyna2-SmFy1o3DvCgRRMwIf4_AouCWEf1W1SCf6Bl3X-Iz2rz0hqFRQxBGS4iPob3fOTS-FjsH-N7NqbKECrwlK3TjPvqwb59-j68SSr2nSVOxq3NCmCjjkme1PpStmoN675Y4GDQcORxeyBJ3QnEe-VVzgPukOfZtGoazPP6uZMpiDxPEcIhp8fVMQz1IltzL3vTE2ty5h6dFNKW_tbhexvKLBhZfH-yTOAoEafiRoF8RWZcbbCtcBdfF_oStLnm0ZsVeSz6TkD1m86ebYHAQMKCZO4i_zmKuT5IdjbBGzxF4bm8Jq6-_Xq1Bypd9W9qD0GLiYLyM6uU8gTWJ-MUIQv1VqFHC5S8kc2HUYjoCRKWBxNbBWiAzD41KFqcsYnRGvL-vRqW3ak=\" rel=\"nofollow\" target=\"_blank\">www.belitebio.com<\/a>.<\/p>\n<p>\n        <strong>Media and Investor Relations Contacts:<\/strong><br \/>\n        <br \/>\n        <strong>Jennifer Wu\u00a0\/\u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ry04iIUuhK5vW6saEx2CZ9WtOXCbYg7N8whDV2UB5P8W7czhhmVV4SDezH2UfyCXSJCy9VCYXcdShulksJKb9AphoFT9cP89t7ExkWSJl1yknHjgJhxQeHvBpkMNSeq5dHipOFdepw5gPMzC8o0epDKNadayaUFYM5U3jrPcH-5PnMzod984Ci5mDpQN1CH5HuATcIy_81kS9S-6kRQj-kTU40b44n0BMJOm_W5_Dwnyi7RqeVEhXQwVnuyWMJbshRkw26v_QmQA3tTAZVJ-YA==\" rel=\"nofollow\" target=\"_blank\">ir@belitebio.com<\/a><br \/>\n        <br \/>\n        <strong>Argot Partners\u00a0\/\u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dkyOlS0gUsvhBne7UP6iOqchwlsWxuZFG-NxsCuC3vJOTpu5yLLdTdroqJwWSaN7UZLsnhFLSwiIAtorCyk_y36lz7qT86cSxczXfQ_EGf2WvCg0RG_XZrJXLBrwlpfbVylWQVaOh8TTXXzj2mQ11jm0xtUEJ6dk-jyQOqCAd3hOQ-biL_NV2O2Z3jQmIgtUkScVgcQUi23tcW-dQROAnuDKuQlPNiTOHtkZve80oo28Lg3xiVEJtc-ac7wgL76kOBBBPxUYXTzz32b7c9opqG7Chwl-A0OPL_esWB6Jr0s=\" rel=\"nofollow\" target=\"_blank\">belite@argotpartners.com<\/a><br \/>\n        <strong>\u00a0<\/strong>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2E2NDg2NzktY2Y4My00NTZmLWFlZTktYTlkNzQ1YzJiMmJmLTEyNDUyODUtMjAyNi0wNC0yMy1lbg==\/tiny\/Belite-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:\u00a0\u00a0 Deutsche Bank American Depositary Receipt Virtual Investor Conference (Virtual) April 28, 2026, at 9:00 am ET, corporate presentation BofA Securities 2026 Health Care Conference (Las Vegas, NV) May 13, 2026, at 3:40 pm PT, fireside chat H.C. Wainwright 4th Annual BioConnect Nasdaq Investor Conference (New York, NY) May 19, 2026, at 5:00 pm ET, fireside chat Stifel 2026 Virtual Ophthalmology Forum (Virtual) May &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Belite Bio to Participate in Four Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954135","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:\u00a0\u00a0 Deutsche Bank American Depositary Receipt Virtual Investor Conference (Virtual) April 28, 2026, at 9:00 am ET, corporate presentation BofA Securities 2026 Health Care Conference (Las Vegas, NV) May 13, 2026, at 3:40 pm PT, fireside chat H.C. Wainwright 4th Annual BioConnect Nasdaq Investor Conference (New York, NY) May 19, 2026, at 5:00 pm ET, fireside chat Stifel 2026 Virtual Ophthalmology Forum (Virtual) May &hellip; Continue reading &quot;Belite Bio to Participate in Four Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-23T12:17:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Belite Bio to Participate in Four Upcoming Investor Conferences\",\"datePublished\":\"2026-04-23T12:17:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/\"},\"wordCount\":303,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/\",\"name\":\"Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\",\"datePublished\":\"2026-04-23T12:17:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-participate-in-four-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Belite Bio to Participate in Four Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:\u00a0\u00a0 Deutsche Bank American Depositary Receipt Virtual Investor Conference (Virtual) April 28, 2026, at 9:00 am ET, corporate presentation BofA Securities 2026 Health Care Conference (Las Vegas, NV) May 13, 2026, at 3:40 pm PT, fireside chat H.C. Wainwright 4th Annual BioConnect Nasdaq Investor Conference (New York, NY) May 19, 2026, at 5:00 pm ET, fireside chat Stifel 2026 Virtual Ophthalmology Forum (Virtual) May &hellip; Continue reading \"Belite Bio to Participate in Four Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-23T12:17:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Belite Bio to Participate in Four Upcoming Investor Conferences","datePublished":"2026-04-23T12:17:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/"},"wordCount":303,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/","name":"Belite Bio to Participate in Four Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=","datePublished":"2026-04-23T12:17:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NTc2OSM3NTUyMzQ1IzIyMzM3MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-participate-in-four-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Belite Bio to Participate in Four Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954135"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954135\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}